ADVM icon

Adverum Biotechnologies

116 hedge funds and large institutions have $693M invested in Adverum Biotechnologies in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 33 increasing their positions, 38 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$13.5M
Puts
$3.69M
Net Calls
Net Calls Change

Top Buyers

1 +$15.2M
2 +$11.5M
3 +$10.9M
4
Goldman Sachs
Goldman Sachs
New York
+$7.03M
5
UBS Group
UBS Group
Switzerland
+$6.14M

Top Sellers

1 -$19.8M
2 -$14.3M
3 -$6.77M
4
Citadel Advisors
Citadel Advisors
Florida
-$6.64M
5
GTC
Ghost Tree Capital
New York
-$3.17M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$377K
77
$366K
78
$342K
79
$329K
80
$306K
81
$297K
82
$270K
83
$247K
84
$245K
85
$242K
86
$235K
87
$233K
88
$230K
89
$228K
90
$222K
91
$209K
92
$206K
93
$188K
94
$180K
95
$179K
96
$172K
97
$170K
98
$150K
99
$117K
100
$93K